Cell Signaling Technology

Phospho-CD19 (Tyr531) Antibody

#3571 · $148

100
Citing papers
13.3k
Combined citations
Supplier page Find this product

Research areas

Autophagy in Disease and Therapy8Epigenetics and DNA Methylation7PARP inhibition in cancer therapy6CRISPR and Genetic Engineering6DNA Repair Mechanisms6Immune Response and Inflammation6Mitochondrial Function and Pathology6Cell Adhesion Molecules Research5

Papers citing this product

1
α-Synuclein Is Localized to Mitochondria-Associated ER Membranes
Journal of Neuroscience·2013·500 cit.·DOI
2
Cartilage Tissue Engineering by the 3D Bioprinting of iPS Cells in a Nanocellulose/Alginate Bioink
Scientific Reports·2017·475 cit.·DOI
3
Toll-like Receptors Induce a Phagocytic Gene Program through p38
The Journal of Experimental Medicine·2003·428 cit.·DOI
4
Differential Requirement for TANK-binding Kinase-1 in Type I Interferon Responses to Toll-like Receptor Activation and Viral Infection
The Journal of Experimental Medicine·2004·400 cit.·DOI
5
Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1.
PubMed·2003·331 cit.
6
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency
Molecular Cell·2021·315 cit.·DOI
7
Inferring and perturbing cell fate regulomes in human brain organoids
Nature·2022·309 cit.·DOI
8
VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for  -Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease
Journal of Neuroscience·2015·270 cit.·DOI
9
Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model
Journal of Neuroscience·2017·257 cit.·DOI
10
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
British Journal of Cancer·2005·217 cit.·DOI